---
title: "Mizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295055160.md"
description: "Mizuho Securities analyst Uy Ear reaffirmed a Buy rating on Evolus (EOLS) with a $15.00 price target, despite shares closing at $6.18. Ear, a 4-star analyst in the Healthcare sector, maintains this stance. The broader market consensus for Evolus is a Moderate Buy with an average price target of $14.00."
datetime: "2026-08-06T04:45:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295055160.md)
  - [en](https://longbridge.com/en/news/295055160.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295055160.md)
generator: "portal-rs"
---

# Mizuho Securities Reaffirms Their Buy Rating on Evolus (EOLS)

Mizuho Securities analyst Uy Ear reiterated a Buy rating on Evolus yesterday and set a price target of $15.00. The company’s shares closed yesterday at $6.18.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Ear is a 4-star analyst with an average return of 6.9% and a 42.57% success rate. Ear covers the Healthcare sector, focusing on stocks such as Alkermes, Evolus, and ACADIA Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Evolus with a $14.00 average price target.

### Related Stocks

- [EOLS.US](https://longbridge.com/en/quote/EOLS.US.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)
- [ALKS.US](https://longbridge.com/en/quote/ALKS.US.md)
- [ACAD.US](https://longbridge.com/en/quote/ACAD.US.md)

## Related News & Research

- [Evolus (EOLS) Receives a Buy from Mizuho Securities](https://longbridge.com/en/news/289108379.md)
- [EOLS: Q2 revenue up 21%, positive EBITDA, raised outlook, and expanded global portfolio for sustained growth](https://longbridge.com/en/news/295022678.md)
- [Lumexa Imaging CEO, CFO to join Wells Fargo healthcare conference fireside chat](https://longbridge.com/en/news/296901710.md)
- [Royaland adds Nazario Matachione to board of directors](https://longbridge.com/en/news/296926591.md)
- [88,309 Shares in UnitedHealth Group Incorporated $UNH Purchased by Allworth Financial LP](https://longbridge.com/en/news/296749626.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**